Gary L. Crocker is President of Crocker Ventures, LLC, a life science private investment firm. He was Utah Entrepreneur of the year in 1999. He is on the Board of Directors of the Federal Reserve Branch of San Francisco and also serves as a member of the Advisory Board of Sorenson Capital, an LBO private equity fund. He has held senior executive or director level positions in several successful life science firms including service from 1998 to 2003 as Chairman of ARUP Laboratories, as a director of Interleukin Genetics, Inc, and LineaGen Genetics, LLC., and as a co-founder and director of Theratech, Inc. which was acquired in 1999 by Waton Pharmaceuticals. From 1983 to 1997, he was President/CEO and founder of Research Medical, Inc., a publicly traded cardiac device manufacturer acquired by Baxter International in 1997. Prior to Research Medical, Mr. Crocker was Vice President, Business Development and Director of Marketing for the Sorenson Research division of Abbott Laboratories, and an Internal Strategic Analyst for Baxter International. He was recently inducted into the University of Utah Science Hall of Fame, and serves as a director of the University's Research Foundation. Mr. Crocker earned both his MBA and also graduated magna cum laude with a Bachelor of Science degree in Economics from Harvard University.
The Entrepreneurs 10 Commandments
Posts
3 comments:
I thought this was awesome. Thanks President Crocker! And thanks Mitch for putting all this together. Entrepreneurship has been at the forefront of my mind for years, and this was right down my alley. The one question I didn't get to ask, was where do most of your 4-5 business plans/week come from, President Crocker? Is it word of mouth, or do you put feelers out in certain arenas?
I loved it, can't wait for the coming months!
I really appreciated the tips given by President Crocker. Just a suggestion for future sessions: I would love to see a couple speakers address young people who are recent college graduates and trying to start a career. Thanks!
Post a Comment